High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement

Acta Haematol (2017) 137 (2): 93–99.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Brentuximab Vedotin for Refractory Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma in Leukemic Phase with RUNX3 Overexpression

Yusuke Yamashita
Yoshikazu Hori
Hideki Kosako
Takehiro Oiwa
Kenji Warigaya
Toshiki Mushino
Shogo Murata
Masakazu Fujimoto
Akinori Nishikawa
Shin-ichi Murata
Takashi Sonoki
Shinobu Tamura

Hematology Reports (2020) 12 (1): 8368.

The combination of methotrexate and cytosine arabinoside in newly diagnosed adult Langerhans cell histiocytosis: a prospective phase II interventional clinical trial

Xiao Han
Mingqi Ouyang
Minghui Duan
Wei Zhang
Tienan Zhu
Jian Li
Shujie Wang
Daobin Zhou

BMC Cancer (2020) 20 (1)

Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma

Kento Umino
Shin-Ichiro Fujiwara
Takashi Ikeda
Shin-Ichiro Kawaguchi
Yumiko Toda
Shoko Ito
Shin-Ichi Ochi
Takashi Nagayama
Kiyomi Mashima
Daisuke Minakata
Hirofumi Nakano
Ryoko Yamasaki
Kaoru Morita
Yasufumi Kawasaki
Chihiro Yamamoto
Masahiro Ashizawa
Kaoru Hatano
Kazuya Sato
Iekuni Oh
Ken Ohmine
Kazuo Muroi
Yoshinobu Kanda

Leukemia & Lymphoma (2019) 60 (8): 1926.

UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma

Xiaoxi Li
Yanli Zhang
Liting Zheng
Mingxian Liu
Charlie Degui Chen
Hai Jiang

Nature Communications (2018) 9 (1)